Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 655pembrolizumab 605Magnetic Resonance Spectroscopy 562Carboplatin 445Cisplatin 396Cyclophosphamide 394Biopsy 378Nivolumab 323Paclitaxel 320Gemcitabine 313Radiotherapy 293Bevacizumab 248Dexamethasone 221fludarabine 212Docetaxel 201durvalumab 193atezolizumab 186Oxaliplatin 186venetoclax 182Fluorouracil 175Rituximab 173Pemetrexed 172Capecitabine 170Radiation 166Doxorubicin 166Radiosurgery 158Ipilimumab 145Etoposide 142Leucovorin 140Lenalidomide 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
2,2'-dithiodiethanesulfonic acid × 90 days × Clear all
NCT05456256 2026-05-04

HARMONIC

Lantern Pharma Inc.

Phase 2 Recruiting
90 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡